Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cloverty (formerly HC Clover PS) is a Spanish contract development and manufacturing organization (CDMO) specializing in the development, formulation, and manufacturing of soft gelatin capsules. Founded in 2008 and headquartered in Madrid, Spain, the company provides end-to-end services—from R&D and regulatory support to primary and secondary packaging—for the pharmaceutical, nutraceutical, nutricosmetic, and veterinary industries. Cloverty operates state-of-the-art manufacturing facilities in Spain and Brazil (via its joint venture Clover do Brasil), producing over 1.8 billion capsules annually. Backed by MCH Private Equity, the company serves clients in over 45 countries globally, partnering with major pharmaceutical and healthcare brands.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on HC Clover.